# Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension

> **NCT03566329** · PHASE1 · UNKNOWN · sponsor: **Ahmed Mohamed ELbadawy** · enrollment: 90 (estimated)

## Conditions studied

- Craniotomy
- Hypertension

## Interventions

- **DRUG:** Magnesium sulphate
- **DRUG:** Lidocaine Hydrochloride
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03566329
- **Lead sponsor:** Ahmed Mohamed ELbadawy
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-10
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03566329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03566329, "Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03566329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*